HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 1, 2025
HTG Molecular Diagnostics Market Cap
HTG Molecular Diagnostics has a market cap or net worth of $221.00 as of July 25, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
221.00
Enterprise Value
n/a
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 7, 2015, HTG Molecular Diagnostics's market cap has decreased from 93.88M to 221.00, a decrease of -100.00%. That is a compound annual growth rate of -72.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 221.00 | - |
| Dec 31, 2024 | 221.00 | -92.32% |
| Dec 29, 2023 | 2.88K | -99.92% |
| Dec 30, 2022 | 3.67M | -91.04% |
| Dec 31, 2021 | 41.02M | 80.67% |
| Dec 31, 2020 | 22.70M | -44.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.92M |
| Glass House Brands | 416.79M |
| Northwest Biotherapeutics | 377.15M |
| CytoDyn | 376.49M |